Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ethosuximide kinetics: possible interaction with valproic acid.

L A Bauer, C Harris, A J Wilensky

    Clinical Pharmacology and Therapeutics
    |June 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Alloanti-Hy in antenatal patients: A multi-case review.

    Transfusion medicine (Oxford, England)·2025
    Same author

    School-based indicated prevention interventions for anxiety in children and adolescents: A commentary on a systematic review.

    British journal of child health·2024
    Same author

    First Study of the ^{139}Ba(n,γ)^{140}Ba Reaction to Constrain the Conditions for the Astrophysical i Process.

    Physical review letters·2024
    Same author

    Proton Shell Gaps in N=28 Nuclei from the First Complete Spectroscopy Study with FRIB Decay Station Initiator.

    Physical review letters·2024
    Same author

    Anaesthesia for pelvic exenteration surgery.

    BJA education·2024
    Same author

    The effectiveness and safety of heat/cold therapy in adults with lymphoedema: systematic review.

    Disability and rehabilitation·2023
    Same journal

    Symposium Report: Stakeholders' Perspectives on Phase 1 Trials in Japanese Prior to Multi-Regional Clinical Trials and Future Pathways.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Resolving CYP2D6 Structural Complexity with Long-Read Sequencing: Implications for Tamoxifen Precision Dosing in Thai Breast Cancer Patients.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Identification of a Functional CYP2C8 Variant Allele that Alters Splicing, Reduces Protein Expression, and Increases Drug Exposure.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin-Angiotensin System Inhibitors.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Composite Endpoints in Contemporary Cardiovascular Trials: Trends in Phase 3 Trials and Key Issues in Regulatory Review.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data.

    Clinical pharmacology and therapeutics·2026
    See all related articles

    Ethosuximide clearance decreases slightly with steady-state dosing in healthy adults. Adding valproic acid did not alter ethosuximide pharmacokinetics, but some patients showed nonlinear kinetics.

    Area of Science:

    • Pharmacology
    • Clinical Pharmacy
    • Neuroscience

    Background:

    • Ethosuximide is a primary antiepileptic drug for absence seizures.
    • Understanding its pharmacokinetics is crucial for optimizing treatment and minimizing adverse effects.
    • Potential drug interactions and nonlinear kinetics can complicate therapeutic drug monitoring.

    Purpose of the Study:

    • To determine ethosuximide pharmacokinetics in healthy adults after single and steady-state dosing.
    • To investigate potential drug interactions between ethosuximide and valproic acid.
    • To evaluate the presence of nonlinear kinetics in patients treated with ethosuximide.

    Main Methods:

    • Pharmacokinetic analysis of ethosuximide in six healthy adults across three phases: single dose, steady-state, and co-administration with valproic acid.

    Related Experiment Videos

  • Retrospective review of 106 patients receiving ethosuximide monotherapy for absence seizures to assess nonlinear kinetics.

    • Main Results:

    • Total and nonrenal clearance of ethosuximide decreased significantly (P < 0.05) between single and steady-state dosing.
    • Co-administration of valproic acid did not alter ethosuximide total or nonrenal clearance.
    • Analysis of patients revealed evidence of nonlinear ethosuximide kinetics in a subset of individuals.

    Conclusions:

    • Ethosuximide exhibits reduced clearance at steady-state compared to single dosing in healthy adults.
    • Valproic acid does not appear to interact with ethosuximide pharmacokinetics.
    • Nonlinear pharmacokinetics may be a factor in some patients receiving ethosuximide, necessitating careful dose individualization.